Skip to main content
. 2022 Apr 14;219(6):e20212553. doi: 10.1084/jem.20212553

Figure S2.

Figure S2.

Characterization of BND cells in other patient populations. (A–C) Expression (geometric mean fluorescent intensity) of CD68, CD86, CD22, and CD72 on BND cells ex vivo from healthy controls (n = 10; A), those immunized against SARS-CoV-2 (n = 15; B) or subjects mildly infected with SARS-CoV-2 (n = 11; C). Statistics: one-way ANOVA; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.